Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China flag China · Delayed Price · Currency is CNY
6.02
-0.19 (-3.06%)
Apr 25, 2025, 3:04 PM CST

SHE:002550 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Operating Revenue
1,5161,5261,8092,3021,8741,667
Upgrade
Other Revenue
--5.171.131.020.54
Upgrade
Revenue
1,5161,5261,8142,3041,8751,668
Upgrade
Revenue Growth (YoY)
-9.06%-15.88%-21.24%22.86%12.43%-0.45%
Upgrade
Cost of Revenue
678.62689.071,0451,4191,045880.42
Upgrade
Gross Profit
837.4837.18768.81884.31829.44787.19
Upgrade
Selling, General & Admin
423.55427.72521.42541.03587.29483.04
Upgrade
Research & Development
103.36104.4597.0888.3171.1869.14
Upgrade
Other Operating Expenses
6.510.5315.0617.118.3519.96
Upgrade
Operating Expenses
533.42542.69614.55661.74677.06577.18
Upgrade
Operating Income
303.99294.48154.26222.56152.38210.01
Upgrade
Interest Expense
---5.93-5.23-1.66-8.44
Upgrade
Interest & Investment Income
10.8511.5319.35.641.621.61
Upgrade
Currency Exchange Gain (Loss)
--1.2674.02-5.4-17.71
Upgrade
Other Non Operating Income (Expenses)
150.8290.56-1.83-0.0252.55-378.37
Upgrade
EBT Excluding Unusual Items
465.66396.57167.07296.97199.48-172.91
Upgrade
Gain (Loss) on Sale of Investments
3.472.360.77-4.590.640.44
Upgrade
Gain (Loss) on Sale of Assets
--25.3557.59--
Upgrade
Asset Writedown
-3.09-3.09-7.77-0.24-0.46-1.6
Upgrade
Other Unusual Items
--18.1110.69.724.95
Upgrade
Pretax Income
466.04395.84203.52360.33209.38-169.12
Upgrade
Income Tax Expense
76.5962.6624.8540.4223.04-21.49
Upgrade
Earnings From Continuing Operations
389.45333.18178.67319.91186.34-147.63
Upgrade
Minority Interest in Earnings
23.4522.853.193.5-5.2615.61
Upgrade
Net Income
412.89356.03181.86323.41181.08-132.02
Upgrade
Net Income to Common
412.89356.03181.86323.41181.08-132.02
Upgrade
Net Income Growth
106.42%95.77%-43.77%78.60%--
Upgrade
Shares Outstanding (Basic)
1,2691,2721,2991,2941,2071,200
Upgrade
Shares Outstanding (Diluted)
1,2691,2721,2991,2941,2071,200
Upgrade
Shares Change (YoY)
-1.91%-2.11%0.41%7.16%0.58%-4.01%
Upgrade
EPS (Basic)
0.330.280.140.250.15-0.11
Upgrade
EPS (Diluted)
0.330.280.140.250.15-0.11
Upgrade
EPS Growth
110.44%100.00%-44.00%66.67%--
Upgrade
Free Cash Flow
311.39424.07433-142.4613.19254.74
Upgrade
Free Cash Flow Per Share
0.240.330.33-0.110.010.21
Upgrade
Dividend Per Share
--0.1200.1200.1200.120
Upgrade
Dividend Growth
------52.00%
Upgrade
Gross Margin
55.24%54.85%42.38%38.39%44.24%47.21%
Upgrade
Operating Margin
20.05%19.30%8.50%9.66%8.13%12.59%
Upgrade
Profit Margin
27.23%23.33%10.02%14.04%9.66%-7.92%
Upgrade
Free Cash Flow Margin
20.54%27.79%23.87%-6.18%0.70%15.28%
Upgrade
EBITDA
369.05359.97221.45287.33221.82280.26
Upgrade
EBITDA Margin
24.34%23.59%12.21%12.47%11.83%16.81%
Upgrade
D&A For EBITDA
65.0665.4967.1964.7669.4370.25
Upgrade
EBIT
303.99294.48154.26222.56152.38210.01
Upgrade
EBIT Margin
20.05%19.30%8.50%9.66%8.13%12.59%
Upgrade
Effective Tax Rate
16.43%15.83%12.21%11.22%11.00%-
Upgrade
Revenue as Reported
--1,8142,3041,8751,668
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.